is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Detailed information on Almirall S.A. required for business and competitor intelligence needs
A study of the major internal and external factors affecting Almirall S.A. in the form of a SWOT analysis
An in-depth view of the business model of Almirall S.A. including a breakdown and examination of key business segments
Intelligence on Almirall S.A.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Almirall S.A., such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Almirall (or 'the group') is principally engaged in the research, development, storage, and commercialization of proprietary drugs as well as licensed products. Its products are sold in over 70 countries, with a direct presence in Europe, the US and Mexico. Almirall is headquartered in Barcelona, Spain, and employed about 2,130 people as of December 31, 2014.
Reasons to Purchase:
Gain understanding of Almirall S.A. and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess Almirall S.A. as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on Almirall S.A.’s business structure, strategy and prospects